Pii’s access to multiple delivery technologies and experience with a wide range of dosage forms provides you with the capabilities and talent needed to develop a robust formulation and move your compound to the next stage.
Join our Mailing List
Drug Delivery Solutions
As the number of challenging compounds coming out of drug discovery increases, conventional formulation strategies may no longer suffice in providing acceptable bioavailability and targeted clinical profiles. Advanced delivery technologies become an essential approach in the development of new chemical entities.
To address this growing need, Pii offers a broad portfolio of drug delivery solutions to meet each molecule’s specific needs. From bioavailability enhancement technologies and solid dispersion development to controlled release, our capabilities cover the spectrum of drug delivery.
Since 1994, Pii has provided solutions for difficult to formulate compounds, tight timelines and challenging development goals. Having successfully developed more than 400 compounds, Pii has the experience and capabilities to rapidly take your compound from the conceptual stage to commercial launch. Choosing a provider with proven experience and know-how such as Pii, will help to formulate your challenging compounds to reach their full potential. Our focus is to rapidly take your compound from prototype development and CTM manufacturing to scale up and commercial launch.
One Size Does NOT Fit All
Designing an efficient drug delivery system is not a one size fits all approach. When selecting the right drug delivery technology, a number of important factors need to be considered. To be successful, it is important to carefully tailor the development process to the characteristics of the API. From API in a Capsule to solid dispersions, Pii has the right tools and breadth of experience to meet your goals and the specific need’s of each compound. Our “one-size-does-not-fit-all” approach ensures the best technology is chosen for your compound, therefore avoiding future development obstacles, costly reformulation, and timeline delays.
Our portfolio of drug delivery technologies includes:
First-In-Man Fast Formulations
Learn More about our First In Man Fast development program
Solid Dispersion Development
Particle Size Reduction